U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    Tmem106b transmembrane protein 106B [ Mus musculus (house mouse) ]

    Gene ID: 71900, updated on 27-Nov-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Lysosomal TMEM106B interacts with galactosylceramidase to regulate myelin lipid metabolism.

    Lysosomal TMEM106B interacts with galactosylceramidase to regulate myelin lipid metabolism.
    Takahashi H, Perez-Canamas A, Lee CW, Ye H, Han X, Strittmatter SM., Free PMC Article

    10/25/2024
    Association of TMEM106B with Cortical APOE Gene Expression in Neurodegenerative Conditions.

    Association of TMEM106B with Cortical APOE Gene Expression in Neurodegenerative Conditions.
    Picard C, Miron J, Poirier J., Free PMC Article

    05/20/2024
    Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice.

    Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice.
    Feng T, Du H, Yang C, Wang Y, Hu F.

    03/31/2024
    TMEM106B coding variant is protective and deletion detrimental in a mouse model of tauopathy.

    TMEM106B coding variant is protective and deletion detrimental in a mouse model of tauopathy.
    Edwards GA 3rd, Wood CA, He Y, Nguyen Q, Kim PJ, Gomez-Gutierrez R, Park KW, Xu Y, Zurhellen C, Al-Ramahi I, Jankowsky JL.

    03/31/2024
    TMEM106B regulates microglial proliferation and survival in response to demyelination.

    TMEM106B regulates microglial proliferation and survival in response to demyelination.
    Zhang T, Pang W, Feng T, Guo J, Wu K, Nunez Santos M, Arthanarisami A, Nana AL, Nguyen Q, Kim PJ, Jankowsky JL, Seeley WW, Hu F., Free PMC Article

    05/13/2023
    Lack of a protective effect of the Tmem106b "protective SNP" in the Grn knockout mouse model for frontotemporal lobar degeneration.

    Lack of a protective effect of the Tmem106b "protective SNP" in the Grn knockout mouse model for frontotemporal lobar degeneration.
    Cabron AS, Borgmeyer U, Richter J, Peisker H, Gutbrod K, Dörmann P, Capell A, Damme M., Free PMC Article

    02/4/2023
    TMEM106B deficiency impairs cerebellar myelination and synaptic integrity with Purkinje cell loss.

    TMEM106B deficiency impairs cerebellar myelination and synaptic integrity with Purkinje cell loss.
    Feng T, Luan L, Katz II, Ullah M, Van Deerlin VM, Trojanowski JQ, Lee EB, Hu F., Free PMC Article

    05/7/2022
    Aged Tmem106b knockout mice display gait deficits in coincidence with Purkinje cell loss and only limited signs of non-motor dysfunction.

    Aged Tmem106b knockout mice display gait deficits in coincidence with Purkinje cell loss and only limited signs of non-motor dysfunction.
    Stroobants S, D'Hooge R, Damme M., Free PMC Article

    12/25/2021
    Loss of TMEM106B potentiates lysosomal and FTLD-like pathology in progranulin-deficient mice.

    Loss of TMEM106B potentiates lysosomal and FTLD-like pathology in progranulin-deficient mice.
    Werner G, Damme M, Schludi M, Gnörich J, Wind K, Fellerer K, Wefers B, Wurst W, Edbauer D, Brendel M, Haass C, Capell A., Free PMC Article

    05/8/2021
    Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice.

    Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice.
    Feng T, Mai S, Roscoe JM, Sheng RR, Ullah M, Zhang J, Katz II, Yu H, Xiong W, Hu F., Free PMC Article

    05/8/2021
    Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin-deficient mice.

    Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin-deficient mice.
    Zhou X, Brooks M, Jiang P, Koga S, Zuberi AR, Baker MC, Parsons TM, Castanedes-Casey M, Phillips V, Librero AL, Kurti A, Fryer JD, Bu G, Lutz C, Dickson DW, Rademakers R., Free PMC Article

    05/8/2021
    Progranulin and TMEM106B: when two become wan.

    Progranulin and TMEM106B: when two become wan.
    Clayton EL, Isaacs AM., Free PMC Article

    05/1/2021
    The FTLD Risk Factor TMEM106B Regulates the Transport of Lysosomes at the Axon Initial Segment of Motoneurons.

    The FTLD Risk Factor TMEM106B Regulates the Transport of Lysosomes at the Axon Initial Segment of Motoneurons.
    Lüningschrör P, Werner G, Stroobants S, Kakuta S, Dombert B, Sinske D, Wanner R, Lüllmann-Rauch R, Wefers B, Wurst W, D'Hooge R, Uchiyama Y, Sendtner M, Haass C, Saftig P, Knöll B, Capell A, Damme M.

    03/27/2021
    A role of the frontotemporal lobar degeneration risk factor TMEM106B in myelination.

    A role of the frontotemporal lobar degeneration risk factor TMEM106B in myelination.
    Feng T, Sheng RR, Solé-Domènech S, Ullah M, Zhou X, Mendoza CS, Enriquez LCM, Katz II, Paushter DH, Sullivan PM, Wu X, Maxfield FR, Hu F., Free PMC Article

    01/2/2021
    Data show that the frontotemporal dementia (FTD)-causing C-terminal truncation of CHMP2B results in dendritic endolysosomal trafficking defects. Strikingly, we found that this trafficking defect could be rescued by the knockdown of the FTD risk factor Tmem106b.

    Frontotemporal dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue by TMEM106B knockdown.
    Clayton EL, Milioto C, Muralidharan B, Norona FE, Edgar JR, Soriano A, Jafar-Nejad P, Rigo F, Collinge J, Isaacs AM., Free PMC Article

    07/20/2019
    This work suggests that the protective TMEM106B haplotype may exert its effect in expansion carriers by counteracting lysosomal dysfunction resulting from a loss of C9ORF72.

    Loss of Tmem106b is unable to ameliorate frontotemporal dementia-like phenotypes in an AAV mouse model of C9ORF72-repeat induced toxicity.
    Nicholson AM, Zhou X, Perkerson RB, Parsons TM, Chew J, Brooks M, DeJesus-Hernandez M, Finch NA, Matchett BJ, Kurti A, Jansen-West KR, Perkerson E, Daughrity L, Castanedes-Casey M, Rousseau L, Phillips V, Hu F, Gendron TF, Murray ME, Dickson DW, Fryer JD, Petrucelli L, Rademakers R., Free PMC Article

    06/1/2019
    TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins.

    TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins.
    Kundu ST, Grzeskowiak CL, Fradette JJ, Gibson LA, Rodriguez LB, Creighton CJ, Scott KL, Gibbons DL., Free PMC Article

    12/22/2018
    Grn and Tmem106b genes have opposite effects on lysosomal enzyme levels, and their interaction determines the extent of neurodegeneration

    Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice.
    Klein ZA, Takahashi H, Ma M, Stagi M, Zhou M, Lam TT, Strittmatter SM., Free PMC Article

    09/16/2017
    Regulated intramembrane proteolysis of the frontotemporal lobar degeneration risk factor, TMEM106B, by signal peptide peptidase-like 2a (SPPL2a).

    Regulated intramembrane proteolysis of the frontotemporal lobar degeneration risk factor, TMEM106B, by signal peptide peptidase-like 2a (SPPL2a).
    Brady OA, Zhou X, Hu F., Free PMC Article

    10/4/2014
    firstprevious page of 1 nextlast